common.study.topics.clinical

Biomarker of Transdermal Vagus Nerve Stimulation

common.study.values.description

“Salivary Alpha Amylase as a Biomarker of Transdermal Vagus Nerve Stimulation”

The proposed project tests the hypothesis that salivary alpha amylase concentration is a reliable biomarker of the effect of transdermal vagus nerve stimulation (tVNS) in humans.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

No pharmaceutical medication involved common.study.methods.has-drugs-no
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Transdermal Vagus Nerve Stimulation

intermittent transdermal stimulation of the aurical vagus

participant.views.study.view.additional

participant.views.study.view.scientific-title

Salivary Alpha Amylase as a Biomarker of Transdermal Vagus Nerve Stimulation

common.study.values.clinical-trial-id

NCT03854539

participant.views.study.view.id

eERXma